Pages that link to "Q54262512"
Jump to navigation
Jump to search
The following pages link to Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection (Q54262512):
Displaying 50 items.
- A new strategy to fight antimicrobial resistance: the revival of old antibiotics (Q21131083) (← links)
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (Q22242958) (← links)
- A comparison of different antibiotic regimens for the treatment of infective endocarditis (Q24185887) (← links)
- Antibiotics for bacteraemia due to Staphylococcus aureus (Q24186950) (← links)
- Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds (Q24202424) (← links)
- Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic (Q24614464) (← links)
- Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole (Q24620644) (← links)
- Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus (Q24631182) (← links)
- Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis (Q28368185) (← links)
- Methicillin-Resistant Staphylococcus aureus Infections (Q30306476) (← links)
- Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs (Q33245188) (← links)
- Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic (Q33264142) (← links)
- Oral Antimicrobial Therapy: Efficacy and Safety for Methicillin-Resistant Staphylococcus aureus Infections and Its Impact on the Length of Hospital Stay (Q33418076) (← links)
- A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis (Q33628238) (← links)
- Drug-resistant pathogens in community- and hospital-acquired pneumonia (Q33749663) (← links)
- Antimicrobial susceptibility of coagulase-negative staphylococci (Q33760227) (← links)
- MRSA: treating people with infection. (Q33850476) (← links)
- Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management (Q33928647) (← links)
- Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community (Q33970752) (← links)
- Antibiotics and bacterial resistance in the 21st century (Q34156349) (← links)
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children (Q34157657) (← links)
- Clinical management of Staphylococcus aureus bacteremia: a review (Q34441035) (← links)
- Co-trimoxazole–Sensitive, Methicillin-ResistantStaphylococcus aureus, Israel, 1988–1997 (Q34469972) (← links)
- Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. (Q34478074) (← links)
- Infective endocarditis in intravenous drug abusers and HIV-1 infected patients (Q34715522) (← links)
- Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative? (Q34979705) (← links)
- Methicillin-resistant Staphylococcus aureus in HIV-infected patients (Q35026548) (← links)
- Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina (Q35035275) (← links)
- Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model (Q35116133) (← links)
- Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review (Q35119494) (← links)
- A review of the current place of glycopeptides in turkish medical practice (Q35134138) (← links)
- Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients (Q35182561) (← links)
- Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin (Q35273507) (← links)
- Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications (Q35376362) (← links)
- Development of drugs for antimicrobial-resistant pathogens (Q35587119) (← links)
- Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections (Q35638010) (← links)
- No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period (Q35785093) (← links)
- Predictors of mortality in Staphylococcus aureus Bacteremia (Q35940556) (← links)
- Community-associated methicillin-resistant Staphylococcus aureus: a review (Q36070903) (← links)
- Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance (Q36086509) (← links)
- Staphylococcal skin infections in children: rational drug therapy recommendations (Q36116435) (← links)
- Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient (Q36161246) (← links)
- Impact of community-associated, methicillin-resistant Staphylococcus aureus on management of the skin and soft tissue infections in children (Q36233549) (← links)
- Management of healthcare-associated methicillin-resistant Staphylococcus aureus (Q36322109) (← links)
- Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci (Q36325685) (← links)
- Clinical and laboratory features of community-associated methicillin-resistant Staphylococcus aureus: is it really new? (Q36390527) (← links)
- Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. (Q36409465) (← links)
- Community-associated meticillin-resistant Staphylococcus aureus (Q36438720) (← links)
- Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin. (Q36642946) (← links)
- Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections (Q36718474) (← links)